Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease

Nature Genetics

Volumn 40, Issue 10, 2008, Pages 1211-1215

  Kugathasan, Subra ^a,b   Baldassano, Robert N ^c   Bradfield, Jonathan P ^c   Sleiman, Patrick M A ^c   Imielinski, Marcin ^c   Guthery, Stephen L ^d   Cucchiara, Salvatore ^e   Kim, Cecilia E ^c   Frackelton, Edward C ^c   Annaiah, Kiran ^c   Glessner, Joseph T ^c   Santa, Erin ^c   Willson, Tara ^f   Eckert, Andrew W ^c   Bonkowski, Erin ^f   Shaner, Julie L ^c   Smith, Ryan M ^c   Otieno, F George ^c   Peterson, Nicholas ^a   Abrams, Debra J ^c   Chiavacci, Rosetta M ^c   Grundmeier, Robert ^c,g   Mamula, Petar ^c   Tomer, Gitit ^f   Piccoli, David A ^c   Monos, Dimitri S ^c   Annese, Vito ^h   Denson, Lee A ^f   Grant, Struan F A ^c,g   Hakonarson, Hakon ^c,g   more..

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 20Q; CHROMOSOME 21Q; CONTROLLED STUDY; CROHN DISEASE; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS;

ADOLESCENT; AGE OF ONSET; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 20; CHROMOSOMES, HUMAN, PAIR 21; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HAPLOTYPES; HUMANS; INFANT; INFLAMMATORY BOWEL DISEASES; LINKAGE (GENETICS); MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 6B; RISK FACTORS;

BACTERIA (MICROORGANISMS);

EID: 52949091918     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.203     Document Type: Article

References (28)

1. Podolsky, D.K. Inflammatory bowel disease. N. Engl. J. Med. 347, 417-429 (2002).
2. Mathew, C.G. & Lewis, C.M. Genetics of inflammatory bowel disease: progress and prospects. Hum. Mol. Genet. 13 (Spec. No. 1), R161-168 (2004).
3. Duerr, R.H. et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461-1463 (2006).
4. Baldassano, R.N. et al. Association of variants of the interleukin-23 receptor gene with susceptibility to pediatric Crohn's disease. Clin. Gastroenterol. Hepatol. 5, 972-976 (2007).
5. Hampe, J. et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet. 39, 207-211 (2007).
6. Rioux, J.D. et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet. 39, 596-604 (2007).
7. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678 (2007).
8. Libioulle, C. et al. Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet. 3, e58 (2007).
9. Parkes, M. et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat. Genet. 39, 830-832 (2007).
10. Baldassano, R.N. et al. Association of the T300A non-synonymous variant of the ATG16L1 gene with susceptibility to paediatric Crohn's disease. Gut 56, 1171-1173 (2007).
11. Moffatt, M.F. et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 448, 470-473 (2007).
12. Meinzer, U. et al. Ileal involvement is age dependent in pediatric Crohn's disease. Inflamm. Bowel Dis. 11, 639-644 (2005).
13. Levine, A. et al. Pediatric onset Crohn's colitis is characterized by genotype-dependent age-related susceptibility. Inflamm. Bowel Dis. 13, 1509-1515 (2007).
14. Dideberg, V. et al. An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases. Hum. Mol. Genet. 16, 3008-3016 (2007).
15. van Heel, D.A. et al. Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors. Hum. Mol. Genet. 11, 1281-1289 (2002).
16. D'Haens, G.R. et al. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 114, 262-267 (1998).
17. D'Haens, G. et al. Endoscopic and histological healing with infliximab antitumor necrosis factor antibodies in Crohn's disease: a European multicenter trial. Gastroenterology 116, 1029-1034 (1999).
18. Ina, K. et al. Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance. J. Immunol. 163, 1081-1090 (1999).
19. Satsangi, J. et al. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet 347, 1212-1217 (1996).
20. Fayad, R., Brand, M.I., Stone, D., Keshavarzian, A. & Qiao, L. Apoptosis resistance in ulcerative colitis: high expression of decoy receptors by lamina propria T cells. Eur. J. Immunol. 36, 2215-2222 (2006).
21. Kim, S., Fotiadu, A. & Kotoula, V. Increased expression of soluble decoy receptor 3 in acutely inflamed intestinal epithelia. Clin. Immunol. 115, 286-294 (2005).
22. Chang, Y.C. et al. Modulation of macrophage differentiation and activation by decoy receptor 3. J. Leukoc. Biol. 75, 486-494 (2004).
23. Wortinger, M.A. et al. Fas ligand-induced murine pulmonary inflammation is reduced by a stable decoy receptor 3 analogue. Immunology 110, 225-233 (2003).
24. Chang, Y.C. et al. Epigenetic control of MHC class II expression in tumor-associated macrophages by decoy receptor 3. Blood 111, 5054-5063 (2008).
25. Hsu, T.L. et al. Modulation of dendritic cell differentiation and maturation by decoy receptor 3. J. Immunol. 168, 4846-4853 (2002).
26. Silverberg, M.S. et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can. J. Gastroenterol. 19 (Suppl. A), 5-36 (2005).
27. Falush, D., Stephens, M. & Pritchard, J.K. Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 164, 1567-1587 (2003).
28. Hakonarson, H. et al. A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature 448, 591-594 (2007).